Rigel pharmaceuticals inc (RIGL)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities
Net income (loss)

21,243

-17,200

-11,490

-20,606

-17,598

3,228

-23,766

-25,557

-24,385

-25,871

-17,660

-19,147

-15,314

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-17,464

-

-6,672

-13,912

-18,193

-22,272

-20,942

-25,391

-22,303

-16,861

-23,824

-22,768

-25,574

-25,472

-25,456

-24,738

-23,174

-25,787

-17,931

-21,474

-20,781

Adjustments to reconcile net income (loss) to net cash used in operating activities:
Stock-based compensation expense

2,024

1,411

2,098

2,653

2,953

2,057

2,995

1,112

1,540

3,059

873

1,100

955

2,666

1,215

2,014

1,438

1,625

1,815

1,909

2,054

3,211

2,080

2,132

2,364

1,563

2,063

1,747

1,793

3,263

3,245

3,011

3,098

3,041

3,090

3,200

3,837

Gain on disposal of assets

-

-

-

-

-

-

-

-

-

0

0

0

732

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on sublease

-

-

-

-

-

-

-

-

-

0

0

0

495

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

171

180

166

173

164

163

159

159

113

113

112

114

126

143

214

260

324

338

287

379

435

507

574

623

655

651

644

628

669

636

635

610

552

526

506

476

447

Non-cash operating lease expense

1,934

-

1,763

1,727

1,691

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net amortization and accretion of discount on short-term investments and term loan

138

156

304

331

282

225

224

183

134

152

91

74

33

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in assets and liabilities:
Accounts receivable, net

-451

-1,441

4,619

1,319

1,537

-

-

-

-

-

-

-

-

0

-95

-100

-8

40

-187

244

-5,644

-

0

0

-5,750

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

242

171

-50

42

203

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid and other current assets

-338

3,673

1,817

-680

863

1,917

11

-769

638

213

-58

107

-65

156

-570

83

-766

878

437

-31

-367

357

-239

-934

94

219

-804

-20

-1,262

1,483

-1,000

959

182

-317

-562

586

255

Other assets

-35

1

-18

-16

-6

83

-26

408

-533

-34

-36

-27

-33

-37

-42

-42

-46

-107

16

-40

-28

-325

-47

-23

-44

-58

-58

-57

-58

-67

-49

-57

-59

-59

-80

-160

55

Accounts payable

-1,945

1,491

-1,116

2,598

-5,212

3,750

-701

1,199

-493

443

118

877

-4,385

4,045

18

-924

-339

2,074

-407

-40

-477

595

-878

739

-2,746

2,878

-1,096

-17

441

309

-524

-10

366

281

-186

189

-131

Accrued compensation

-3,312

1,753

1,203

1,431

-5,520

2,453

2,059

694

-2,313

2,316

1,084

1,038

-1,464

-467

1,433

-33

-3,099

1,890

361

286

882

-804

464

697

-374

-25

171

-568

-3,504

1,376

1,726

588

-4,186

2,754

1,165

819

-2,278

Accrued research and development

735

329

184

-1,552

236

962

307

-378

844

620

-763

-1,059

349

-1,805

984

-537

2,286

-246

906

-155

455

967

256

458

724

-1,091

658

-54

-49

-146

-672

1,736

-861

-

-

-

-

Other accrued liabilities

209

-85

1,877

-312

1,642

-156

666

-2,425

2,184

1,789

484

-476

439

-8

-228

422

-286

28

570

-457

458

-346

149

160

-175

94

-38

-183

-69

-55

421

-988

1,060

1,459

-56

-135

-1,670

Lease liability

-1,417

-1,932

-1,654

-1,617

-1,522

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-23,081

-71

-1,000

-150

25,476

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-3,760

-4,833

-4,834

-4,834

-4,834

-4,833

27,928

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and other long term liabilities

-98

-

-

-

-

120

83

120

-645

-1,853

-1,861

-1,763

-1,296

-1,356

-1,343

-1,329

-1,266

-1,174

-1,160

-1,150

-1,594

-330

-320

-319

-273

-184

-183

-183

-138

-49

-49

-47

-5

652

-82

-81

-123

Net cash used in operating activities

-3,093

-9,649

-14,641

-16,651

-569

11,644

-20,082

-26,994

-23,394

-19,715

-17,610

-19,470

-20,762

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Investing activities
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-22,420

-

-9,457

-18,146

17,987

-15,004

-18,377

-19,944

-16,428

-18,902

-20,743

-21,321

-25,111

-21,571

-19,625

-20,740

-23,273

-18,654

-12,793

-17,165

-20,763

Purchases of short-term investments

13,352

44,826

40,623

40,007

19,871

27,938

8,439

36,384

5,235

52,626

19,315

11,535

33,385

20,530

14,628

20,449

47,446

41,881

27,084

32,821

49,977

46,935

46,602

45,420

79,637

-

-

-

-

-

-

-

-

-

-

-

-

Maturities of short-term investments

38,420

37,820

40,681

25,450

19,175

30,100

24,450

20,866

28,650

17,439

26,932

19,905

32,544

22,559

25,273

39,822

40,996

54,765

57,977

24,600

59,520

63,814

53,866

73,750

90,275

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from disposal of assets

-

-

-

-

-

-

-

-

-

0

0

0

732

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

66,892

108,502

100,934

-

58,272

118,615

105,926

163,416

97,693

176,007

38,922

Maturities of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

81,926

100,480

127,396

-

-

-

-

-

-

-

-

Maturities and sales of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

133,685

-

86,756

69,727

77,573

Capital expenditures

607

611

352

115

377

69

156

684

197

53

56

14

41

6

252

225

321

134

307

73

32

200

-40

75

178

168

128

249

676

601

384

818

1,574

185

561

697

860

Net cash provided by (used in) investing activities

24,461

-7,617

-294

-14,672

-1,073

2,093

15,855

-16,202

23,218

-35,240

7,561

8,356

-150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing activities
Net cash used in investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,771

-

30,646

-8,294

9,511

16,913

7,304

28,255

10,460

23,496

14,906

8,208

25,786

-108,271

19,079

23,973

26,185

17,836

-11,498

-106,977

37,791

Net proceeds from issuances of common stock upon exercise of options and participation in Purchase Plan

1,336

694

10

856

16

1,099

635

987

2,011

1,928

770

469

341

666

314

614

4

634

98

1,012

17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale and issuance of common stock, net of offering costs

-

-

-

-

-

-

-

-

-

65,438

2,567

3,092

43,083

-

-

-

-

-

-

-

-

-

5

661

24

-

-

-

-

136,525

1,196

885

488

903

202

141,622

52

Payments on capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

134

181

234

251

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

-

98

1,012

17

480

5

661

24

-

-

-

-

136,525

1,196

885

488

769

21

141,388

-199

Net increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-29,187

-

21,287

-25,428

27,515

2,389

-11,068

8,972

-5,944

4,823

-5,837

-12,291

675

6,683

650

4,118

3,400

-49

-24,270

17,246

16,829

Net cash provided by financing activities

1,336

694

9,799

856

16

1,099

635

68,149

2,011

67,366

3,337

3,561

43,424

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

22,704

-16,572

-5,136

-30,467

-1,626

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (decrease) increase in cash and cash equivalents

-

-

-

-

-

-

-

-

1,835

-

-6,712

-7,553

22,512

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Supplemental disclosure of cash flow information
Interest paid

203

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-